Literature DB >> 8722936

Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin.

M E Falagas1, M S Klempner.   

Abstract

Babesiosis is a malaria-like, tick-transmitted zoonosis caused by protozoa of the family Piroplasmorida, which includes Babesia and Theileria species. In the United States, the infection is endemic in the Northeast and upper Midwest, although cases have recently been described in Northern California and Washington State. We report a case of babesiosis in a patient infected with HIV who presented with a prolonged fever of unknown origin; the patient had not undergone splenectomy. Parasitemia persisted despite initial clinical improvement after treatment with quinine and clindamycin. Babesiosis was controlled with a maintenance regimen consisting of clindamycin, doxycycline, and high-dose azithromycin, but the infection was not eradicated. Babesiosis should be considered in the differential diagnosis of HIV-infected patients with fevers and/or anemia in areas where the infection is endemic. HIV-infected patients who are severely immunosuppressed, even those without a history of splenectomy, may present with severe manifestations of babesiosis and develop a chronic infection, which may require therapy to prevent relapse of disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8722936     DOI: 10.1093/clinids/22.5.809

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

Review 1.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Lymelight: forecasting Lyme disease risk using web search data.

Authors:  Adam Sadilek; Yulin Hswen; John S Brownstein; Evgeniy Gabrilovich; Shailesh Bavadekar; Tomer Shekel
Journal:  NPJ Digit Med       Date:  2020-02-04

Review 3.  Chronic coinfections in patients diagnosed with chronic lyme disease: a systematic review.

Authors:  Paul M Lantos; Gary P Wormser
Journal:  Am J Med       Date:  2014-06-12       Impact factor: 4.965

Review 4.  Babesiosis.

Authors:  M J Homer; I Aguilar-Delfin; S R Telford; P J Krause; D H Persing
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

Review 5.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Babesiosis: An Update on Epidemiology and Treatment.

Authors:  Jeffrey A. Gelfand; Michael V. Callahan
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

Review 7.  Human babesiosis.

Authors:  Edouard Vannier; Benjamin E Gewurz; Peter J Krause
Journal:  Infect Dis Clin North Am       Date:  2008-09       Impact factor: 5.982

8.  Diagnosis and management of human babesiosis.

Authors:  Subhash Chandra Parija; Dinoop Kp; Hrudya Venugopal
Journal:  Trop Parasitol       Date:  2015 Jul-Dec

9.  Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone.

Authors:  Lauren A Lawres; Aprajita Garg; Vidya Kumar; Igor Bruzual; Isaac P Forquer; Isaline Renard; Azan Z Virji; Pierre Boulard; Eduardo X Rodriguez; Alexander J Allen; Sovitj Pou; Keith W Wegmann; Rolf W Winter; Aaron Nilsen; Jialing Mao; Douglas A Preston; Alexia A Belperron; Linda K Bockenstedt; David J Hinrichs; Michael K Riscoe; J Stone Doggett; Choukri Ben Mamoun
Journal:  J Exp Med       Date:  2016-06-06       Impact factor: 14.307

Review 10.  Human babesiosis in Europe: what clinicians need to know.

Authors:  A Hildebrandt; J S Gray; K-P Hunfeld
Journal:  Infection       Date:  2013-10-09       Impact factor: 7.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.